Figure 2 | Scientific Reports

Figure 2

From: Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells

Figure 2

(a) Flow cytometry analysis representing the percentage of CD56+ cells non-transduced (mock) on the left and transduced with the CD19-CAR on the right. AB NK cells are representing above and CB NK cells below. (b) Percentage of CD56+ transduced NK cells from both sources, AB (n = 12) and CB (n = 12) 7 days after transduction. The bars represent the mean and error bars represent SEM.

Back to article page